Allmed Medical Products Co., Ltd (002950.SZ)
CNY 8.48
(0.12%)
CNY 8.48
(0.12%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.08 Billion CNY | -11.54% |
| 2022 | 5.74 Billion CNY | 14.84% |
| 2021 | 5 Billion CNY | 3.06% |
| 2020 | 4.85 Billion CNY | 53.88% |
| 2019 | 3.15 Billion CNY | 8.81% |
| 2018 | 2.9 Billion CNY | 27.62% |
| 2017 | 2.27 Billion CNY | 19.77% |
| 2016 | 1.89 Billion CNY | 2.67% |
| 2015 | 1.84 Billion CNY | 5.56% |
| 2014 | 1.75 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.07 Billion CNY | -1.5% |
| 2024 Q1 | 5.15 Billion CNY | 1.36% |
| 2024 Q3 | 5.15 Billion CNY | 1.59% |
| 2023 Q1 | 5.4 Billion CNY | -5.9% |
| 2023 FY | 5.08 Billion CNY | -11.54% |
| 2023 Q4 | 5.08 Billion CNY | -1.77% |
| 2023 Q3 | 5.17 Billion CNY | -2.23% |
| 2023 Q2 | 5.29 Billion CNY | -2.12% |
| 2022 Q3 | 5.54 Billion CNY | -2.06% |
| 2022 Q4 | 5.74 Billion CNY | 3.69% |
| 2022 Q2 | 5.65 Billion CNY | 5.34% |
| 2022 Q1 | 5.37 Billion CNY | 7.34% |
| 2022 FY | 5.74 Billion CNY | 14.84% |
| 2021 Q4 | 5 Billion CNY | 2.59% |
| 2021 Q2 | 4.84 Billion CNY | -8.58% |
| 2021 FY | 5 Billion CNY | 3.06% |
| 2021 Q3 | 4.87 Billion CNY | 0.7% |
| 2021 Q1 | 5.29 Billion CNY | 9.12% |
| 2020 Q3 | 4.63 Billion CNY | 9.66% |
| 2020 Q1 | 3.72 Billion CNY | 18.13% |
| 2020 Q2 | 4.23 Billion CNY | 13.48% |
| 2020 Q4 | 4.85 Billion CNY | 4.68% |
| 2020 FY | 4.85 Billion CNY | 53.88% |
| 2019 Q3 | 3.13 Billion CNY | -3.22% |
| 2019 FY | 3.15 Billion CNY | 8.81% |
| 2019 Q4 | 3.15 Billion CNY | 0.56% |
| 2019 Q2 | 3.24 Billion CNY | -7.92% |
| 2019 Q1 | 3.52 Billion CNY | 21.43% |
| 2018 FY | 2.9 Billion CNY | 27.62% |
| 2018 Q4 | 2.9 Billion CNY | 21.5% |
| 2018 Q3 | 2.38 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2017 Q4 | 2.27 Billion CNY | 0.0% |
| 2017 Q2 | 1.96 Billion CNY | 0.0% |
| 2017 FY | 2.27 Billion CNY | 19.77% |
| 2016 FY | 1.89 Billion CNY | 2.67% |
| 2015 FY | 1.84 Billion CNY | 5.56% |
| 2014 FY | 1.75 Billion CNY | 0.0% |